Effects of Sleeve Gastrectomy and Gastric Bypass on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients: a 2-Year Follow-up

Obesity Surgery

Volumn 26, Issue 6, 2016, Pages 1247-1253

  Griffo, E ^a   Cotugno, M ^a   Nosso, G ^a   Saldalamacchia, G ^a   Mangione, A ^a   Angrisani, L ^b   Rivellese, A A ^a   Capaldo, B ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b General and Laparoscopic Surgery Unit   (Italy)

Author keywords

Bariatric surgery; GLP 1; Lipid metabolism; Postprandial triglycerides

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INCRETIN; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GASTRIC INHIBITORY POLYPEPTIDE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIABETIC PATIENT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; AGED; BLOOD; BODY MASS; COMPLICATION; DIET RESTRICTION; GASTRECTOMY; GASTRIC BYPASS SURGERY; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MORBID OBESITY; PHYSIOLOGY; PROCEDURES;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC BYPASS; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; INCRETINS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 84944711676     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1891-4     Document Type: Article

References (22)

1. Yu J, Zhou X, Li L, et al. The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence. Obes Surg. 2015;25(1):143–58.
2. Moustarah F, Gilbert A, Després JP, et al. Impact of gastrointestinal surgery on cardiometabolic risk. Curr Atheroscler Rep. 2012;4(6):588–96.
3. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;13(14):1724–37.
4. Benetti A, Del Puppo M, Crosignani A, et al. Cholesterol metabolism after bariatric surgery in grade 3 obesity: differences between malabsorptive and restrictive procedures. Diabetes Care. 2013;36(6):1443–7.
5. Pihlajamäki J, Grönlund S, Simonen M, et al. Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding. Metabolism. 2010;59(6):866–72.
6. Pirillo A, Norata GD, Catapano AL. Postprandial lipemia as a cardiometabolic risk factor. Curr Med Res Opin. 2014;30(8):1489–503.
7. Griffo E, Nosso G, Lupoli R, et al. Early improvement of postprandial lipemia after bariatric surgery in obese type 2 diabetic patients. Obes Surg. 2014;24(5):765–70.
8. Waldmann E, Hüttl TP, Göke B, et al. Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients. Lipids Health Dis. 2013;12:82.
9. Umeda LM, Pereira AZ, Carneiro G, et al. Postprandial adiponectin levels are associated with improvements in postprandial triglycerides after Roux-en-Y gastric bypass in type 2 diabetic patients. Metab Syndr Relat Disord. 2013;11(5):343.
10. Patel VJ, Joharapurkar AA, Shah GB, et al. Effect of GLP-1 based therapies on diabetic dyslipidemia. Curr Diabetes Rev. 2014;10(4):238–50.
11. Mells JE, Anania FA. The role of gastrointestinal hormones in hepatic lipid metabolism. Semin Liver Dis. 2013;33(4):343–57.
12. Ben-Shlomo S, Zvibel I, Shnell M, et al. Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol. 2011;54(6):1214–23.
13. Svegliati-Baroni G, Saccomanno S, Rychlicki C, et al. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver Int. 2011;31(9):1285–97.
14. Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009;58(10):1400–7.
15. Kohli R, Bradley D, Setchell KD, et al. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab. 2013;98(4):E708–12.
16. Patti ME, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 2009;17(9):1671–7.
17. Moschetta A. Nuclear receptors and cholesterol metabolism in the intestine. Atheroscler Suppl. 2015;17:9–11.
18. Padilla N, Maraninchi M, Béliard S, et al. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans. Arterioscler Thromb Vasc Biol. 2014;34(10):2330–7.
19. Rao RS, Kini S. GIP and bariatric surgery. Obes Surg. 2011;21(2):244–52.
20. Miyawaki K, Yamada Y, Ban N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. 2002;8(7):738–42.
21. Miyawaki K, Yamada Y, Yano H, et al. Glucose intolerance caused by a defect in the enteroinsular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A. 1999;96(26):14843–7.
22. Brethauer SA, Aminian A, Romero-Talamás H, et al. Can diabetes be surgically cured?: Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–37.